We show that, relative to single null mutants, mice bearing mutations in both Hoxd4 and Rarg display malformations of the basioccipital bone, and ®rst (C1) and second cervical vertebrae (C2) at increased penetrance and expressivity, demonstrating synergy between Hoxd4 and Rarg in the speci®cation of the cervical skeleton. In contrast to Rarg mutants, retinoic acid (RA) treatment on embryonic day 10.5 of Hoxd4 single or Hoxd4;Rarg double mutants does not rescue normal development of C2. Somitic expression of Hoxd4 is not altered in wild-type or Rarg mutant animals before or after RA treatment on day 10.5, suggesting that Hoxd4 and Rarg act in parallel to regulate the expression of target genes directing skeletogenesis. q
Introduction
Retinoid signaling has been a major focus of study in vertebrate development. It has been well described that suf®cient levels of retinoic acid (RA, an active metabolite of vitamin A) must be maintained if development is to proceed normally. During pregnancy, excess exogenous RA leads to congenital malformations, particularly of the limbs and neural crest-derived structures (Means and Gudas, 1995) . In contrast, vitamin A de®ciency (VAD) in rats during gestation results in offspring born with malformed kidneys, heart, eyes, diaphragm, lungs and urogenital tract (Wilson et al., 1953) . Interestingly, recent studies have shown that at least some of the VAD syndrome phenotype can be suppressed by administration of RA at speci®c windows during embryogenesis (Dickman et al., 1997) .
At the cellular level, RA regulates gene expression through nuclear receptors, which act as ligand-dependent transcription factors. There are two families of retinoid nuclear receptors, the Retinoic Acid Receptors (RARs), which are activated by all-trans and 9-cis retinoic acid, and the Retinoid X Receptors (RXRs) which are activated by 9-cis retinoic acid only (Chambon, 1994) . Each family is represented by three genes, Rara, Rarb, and Rarg, and Rxra, Rxrb and Rxrg (Chambon, 1994) . Single and compound null mutants for all of these receptors have revealed both unique and redundant functions during development (Lohnes et al., 1993 Kastner et al., 1994 Kastner et al., , 1997 Mendelsohn et al., 1994; Sucov et al., 1994; Luo et al., 1995 Luo et al., , 1996 Grondona et al., 1996; Ghyselinck et al., 1997) . All combined, the congenital malformations presented by the Rar and Rxr single or compound mutants recapitulate the VAD phenotypes induced in rats deprived of vitamin A in utero (Wilson et al., 1953; Lohnes et al., 1995; Dickman et al., 1997) .
Evidence from tissue culture and in vivo mouse and Xenopus models suggests that retinoic acid-responsive genes are regulated by RAR:RXR heterodimers (Lohnes et al., 1995; Kastner et al., 1997; van der Wees et al., 1998) . These heterodimers regulate target gene expression by binding to polymorphic cis-acting RA-response elements (RAREs) (Chambon, 1996) . A number of in vivo and in vitro observations have implicated Hox genes as likely downstream targets of RAR:RXR transactivation.
Hox genes encode homeodomain-containing transcription factors that confer positional identity along the embryonic anteroposterior (AP) axis (Krumlauf, 1994; Maconochie et al., 1996) . The key to this function is the spatially restricted expression pattern that is characteristic for each Hox gene. Different approaches to the study of Hox gene expression have all converged on retinoid signaling as a primary input.
In vivo studies on expression patterns have shown that, in wild type mice, exogenous RA causes an anterior shift in the expression of endogenous Hoxd3, -d4, -b1, -b2, -b4 and -b5 in the hindbrain (Conlon and Rossant, 1992; Marshall et al., 1992; Folberg et al., 1997 Folberg et al., , 1999 , while in the vertebral column, Hoxa3, -a7, -c8, -a10, -a11 and -d10 are either anteriorized or repressed (Kessel and Gruss, 1991) . Our recent data suggest that RARb is implicated in the Hoxb4 and Hoxd4 RA-response in the CNS, since Rarb null mutants present only a partial anteriorization of these genes upon RA treatment (Folberg et al., 1999) . Studies in Xenopus, using dominant negative forms of RARa and RARb, have shown that signaling by endogenous retinoids is important for the expression of Hox genes within their correct boundaries (Blumberg et al., 1997; Kolm et al., 1997; van der Wees et al., 1998) . Similarly, induction of endogenous Hoxb4 in the chick hindbrain is dependent on RAR-mediated signaling (Gould et al., 1998) .
Consistent with these observations, RAREs have been found in the regulatory region of Hoxa1 (Langston and Gudas, 1992; Frasch et al., 1995) , Hoxb1 Studer et al., 1994; Huang et al., 1998) , Hoxa4 (Packer et al., 1998) , Hoxb4 (Gould et al., 1998) and Hoxd4 (Moroni et al., 1993; Po Èpperl and Featherstone, 1993; Morrison et al., 1996; Zhang et al., 1997) . Through targeted mutagenesis, the Hoxb1 and Hoxa1 3 H RAREs were shown to modulate high levels of early Hoxb1 and Hoxa1 expression in the neuroectoderm and, to a lesser extent, mesoderm Studer et al., 1998) . Likewise, the Hoxb4 RARE de®nes an early-acting neural enhancer (Gould et al., 1998 ). The murine Hoxd4 5 H RARE has been shown to be part of a mesodermal enhancer (Zhang et al., 1997) , while its human counterpart is required to partially recapitulate Hoxd4 expression in the central nervous system of transgenic mice . The Hoxa4 RARE is required for normal expression in the lung, gut and metanephros, and for response to exogenous RA (Packer et al., 1998) . RA is thus an important temporal and spatial regulatory input for the expression of Hox genes.
The above results imply that Hox genes and retinoic acid receptors are involved in common morphogenetic pathways during embryonic development. Hoxd4 is expressed in the paraxial mesoderm with an anterior border of weak expression in somite 5 and strong expression from somite 6 and posteriorly (Folberg et al., 1997) . This expression pattern correlates with the phenotype presented by Hoxd4 null mutants, which consists mainly of cervical vertebrae malformations and homeotic transformations (Horan et al., 1995a) . Interestingly, two of the defects described are a C2 to C1 transformation, and fusion of the basioccipital bone to C1, both of which are also observed in Rarg null mutants (Lohnes et al., 1993; Kastner et al., 1997) . In the present report, we have undertaken a genetic approach to investigate the potential synergism between Hoxd4 and Rarg in the speci®cation of the cervical vertebrae by generation of compound Hoxd4 and Rarg mutant mice. The double mutant mice do not present any novel defects when compared to single mutants. Nevertheless, the frequency and severity of the cervical vertebral phenotypes are strikingly higher, demonstrating that Hoxd4 and Rarg act synergistically in the speci®cation of the cervical vertebrae.
Results

Generation of Hoxd4;Rarg compound mutants
Single mutants for Hoxd4 (Horan et al., 1995a) and Rarg (Lohnes et al., 1993) were mated to generate double heterozygotes, which were viable and fertile. The F1 double heterozygote progeny were intercrossed and generated the nine expected genotypes, from wild-type to double null. From this F2 generation, 71 newborns were collected at birth and prepared for skeleton analysis. Some Hoxd42/2;Rarg1/2 F2 offspring were crossed back to Hoxd41/2;Rarg1/2 animals. Ninety newborns were collected from this F3 generation for skeletal analysis. Forty-seven single Rarg mutants were also obtained from Rarg1/2 intercrosses. Finally, an additional 14 skeletons were generated by wildtype intercrosses. The frequency of genotypes obtained from compound mutant intercrosses did not differ signi®cantly from the expected Mendelian ratio. All specimens were scored blind for skeletal malformations, and then matched to their genotypes.
In two instances, we obtained Hoxd42/2;Rarg2/2 females which achieved sexual maturity and were mated. Both carried their pregnancies to term, giving birth to small litters which they nursed. Double null males were also viable, but infertile, as expected from previous studies (Lohnes et al., 1993) . All double null animals were considerably smaller than wild-type (approximately half the size).
Skeletal abnormalities in Hoxd4;Rarg mice
In the original report, 33% of Hoxd4 mutants exhibited homeotic transformations of C2 to C1 as manifested by an ectopic anterior arch on C2 (C2 to C1 transformation). In 93% of these mice there were malformations of the neural arches of C1, C2 and C3 and 58% presented malformations of the basioccipital bone. These phenotypes showed incomplete penetrance and variable expressivity (Horan et al., 1995a) . Among other defects, Rarg mutants also exhibited an incompletely penetrant C2 to C1 transformation (Lohnes et al., 1993; Kastner et al., 1997) . Similarly, both Hoxd4 and Rarg mutants display a fusion of the basioccipital to C1, again with incomplete penetrance and variable expressivity. Defects of the tracheal cartilages are also observed in Rarg mutants.
In the evaluation of the compound mutant skeletons, we focused mainly on the cervical region. Speci®cally, we analyzed the basioccipital bone, C1 through C7, the hyoid bone and the tracheal rings. In addition, we analyzed the sternum and the ribs, since these structures were affected in Hoxb4 null mutants, and Rarg null mutants occasionally present one extra vertebrosternal rib.
The results of the skeletal analysis are summarized in Table 1 . All the skeletal malformations observed in the compound mutants were found in the single Hoxd4 and Rarg mutants, and were thus limited to the cervical region. Nevertheless, it is evident that for two defects, namely the basioccipital bone malformation and the presence of an ectopic anterior arch on C2, there is a marked increase in both penetrance and expressivity of the phenotype which directly correlates with the genotype. Chi-squared analysis of total penetrance in double null vs. single null animals, and in double vs. single heterozygotes, reveals that they are statistically different with p values less than 0.001 and 0.05, respectively. Basioccipital bone Fusion to aaa
Basioccipital¯at at the caudal end; 1, ventral budding (Kastner et al., 1997, no. 34) ; 11, fusion to anterior arch of the atlas (see Fig. 1b±d ). b These malformations consist of either the presence of an extra bone rostral to the neural arch (most common), or a bifurcation of the neural arch. c These malformations consist of either the presence of bifurcations (most common) or an extra bone rostral to the neural arch. d C2 to C1 homeotic transformation, see Fig. 2b ,c and text for a description of the different expressivity levels. aaa, anterior arch of the atlas. e TA, tuberculum anterior, small ossi®cation characteristic of C6. f The rib anlage was present with different expressivity levels: 1, small ossi®cation; 2, length at least twice the width; 3, full rib attached to the sternum.
Malformation of the basioccipital bone
The basioccipital bone malformation is an extension at the caudal edge, which occasionally results in fusion to the anterior arch of the atlas (aaa). This phenotype was present with varying degrees of severity (or expressivity), which we scored accordingly. In`1/2', the basioccipital bone, which normally has a concave caudal end (Fig. 1a), was¯at (Fig.  1b) . In`1', a protrusion extended posteriorly (Fig. 1c) , referred to as`ventral budding' in another study (Kastner et al., 1997) . In`11', this extension reached C1, resulting in a fusion between the basioccipital bone and the aaa of C1 (Fig. 1d) . The basioccipital phenotype was present in 8% and 11% (the sum of all expressivity levels) of single Hoxd4 or Rarg heterozygotes, in contrast to 33% penetrance in double heterozygotes (Table 1) . These numbers are different by the x 2 -and Fisher Exact test at P values less than 0.025. Additionally, some double heterozygotes presented the greatest degree of expressivity (11), which was never seen in the single mutants.
When comparing single versus double null genotypes, this difference is even more marked. The frequency of basioccipital bone malformation in Rarg or Hoxd4 single null animals was only 3% and 65%, respectively, but was fully penetrant in double null mutants. This is statistically signi®cant by the x 2 -and Fisher Exact test at P values less than 0.001. Again examination of expressivity is revealing. The majority of single null mutants were restricted to the two phenotypes of lesser severity (1/2 and 1), while the majority of double mutants fell into the most severe category (11). The intermediate genotype (Rarg 2/2;Hoxd4 1/2) showed a correspondingly intermediate phenotype (50% penetrance). The other intermediate genotype (Rarg 1/2;Hoxd4 2/2) did not have a strikingly higher penetrance than observed in Hoxd4 mutants (74% vs. 65%). These results demonstrate strongly synergistic interactions between Hoxd4 and Rarg.
C2 to C1 transformation
The other phenotype that strongly correlated with genotype was the presence of an ectopic anterior arch on C2. This malformation was scored at two expressivity levels: the ectopic process was either ossi®ed (more severe) or cartilaginous (less severe) (Fig. 2b,c) . We observed a progressive increase in expressivity and penetrance that correlated with the number of mutant alleles. Thus, this phenotype was absent in Rarg heterozygotes, and present in 4% of Hoxd4 heterozygotes, but rose to 18% in double heterozygotes. This is signi®cant at P values less than 0.05 and 0.025 for the x 2 -and Fisher Exact test, respectively. Similar to the previous phenotype, the difference in penetrance between the single vs. double null genotype was sharp. In single nulls, it was present at 6% (Rarg) or 24% (Hoxd4), whereas 83% of double null mutants presented this phenotype. This is statistically different at P values less than 0.001 by both x 2 -and Fisher Exact test. It is important to note that the frequency observed in double nulls is considerably higher than the total sum of the frequencies of each single null, showing that this is not an additive effect. Again, while the single null mutants were equally distributed among the two levels of expressivity, the further removal of the remaining Hoxd4 allele, or of all Hoxd4 and Rarg alleles, resulted in the majority of animals displaying the most severe phenotype. Our data strongly suggest that the absence of both Hoxd4 and Rarg results in a synergistic effect in the speci®cation of structures in the anterior-most cervical region.
Hoxd4 and Hoxb4 expression patterns are unchanged in Rarg mutants
The Hoxd4;Rarg double null mutants could be interpreted as phenocopies of Hoxd4;Hoxb4 double null mutants, where the C2 to C1 transformation is fully penetrant (Horan et al., 1995b) . This suggests that Hoxb4 somitic expression could be altered in Hoxd4;Rarg double mutants. We therefore analyzed Hoxb4 expression by whole-mount in situ hybridization in day 9.5 compound mutant embryos. In all the embryos analyzed (2 Hoxd42/2;Rarg2/2 and 6 Hoxd42/ 2;Rarg1/2), Hoxb4 expression was comparable to wildtype controls, with an anterior border of expression in somite 6 (Fig. 3) . Thus, the synergistic interaction between Rarg and Hoxd4 mutations cannot be explained by altered expression of Hoxb4 at the developmental stage examined.
We also examined Hoxd4 expression in Rarg 2/2 animals and found no change relative to wild-type (data not shown).
2.6. Vertebral malformations that are abolished by RAtreatment in Rarg single mutants are persistent in Hoxd4 and Hoxd4;Rarg mutants RA treatment of Rarg mutants at embryonic day 10.5 of gestation has been shown to attenuate the C2 to C1 transformation (Iulianella and Lohnes, 1997) . In contrast, 8 out Fig. 3 . Expression of Hoxb4 is unchanged in double mutants of Hoxd4 and Rarg. Whole-mount in situ hybridization was used to detect Hoxb4 transcripts in wild type (a) and double mutant (b) embryos at day 9.5. The anterior expression borders in the hindbrain and somitic column are unchanged. The positions of somites 6, 7 and 8 are indicated, determined by reference to the forelimb bud. of 11 double null mutants treated with RA on day 10.5 presented an ectopic anterior arch on C2. This frequency of 73% is not statistically different from the 83% frequency observed in untreated double null offspring. This result suggests that Hoxd4 is involved in the correction of the phenotype mediated by RA in Rarg single mutants.
To more closely examine the contribution of Hoxd4 to this process, we also assessed Hoxd4 single mutant animals for correction of the C2 morphology. In this experiment, 15% (4/27) of untreated Hoxd42/2 mice and 14% (3/22) of RA-treated Hoxd42/2 animals displayed the C2 to C1 transformation. There was thus no rescue. Together, these results place Hoxd4 downstream or parallel to Rarg in the pathway directing C2 morphogenesis.
To determine whether RA acts directly on Hoxd4 to rescue C2 development, Rarg heterozygotes were mated and the dams administered RA on day 10.5. Hoxd4 expression was assessed by whole-mount in situ hybridization at day 11.5 in treated and control embryos of the three resulting genotypes. Hoxd4 has an anterior border in the CNS at the rhomobmere 6/7 boundary. In mesoderm, somite 5 ®rst presents weak detectable Hoxd4 expression, whereas transcripts are more abundant in somite 6 and posteriorly (Folberg et al., 1997) . Untreated wild type and Rarg null embryos displayed identical anterior borders and similar expression levels in the hindbrain and somitic column (Fig. 4A ). Hoxd4 expression in untreated heterozygotes was likewise unchanged (data not shown.)
Three wild-type, two heterozygous, and two Rarg null embryos exposed to RA were compared to one wild type, two heterozygous, and one null untreated specimens. Six of the RA-treated embryos presented a rupture of the neural tube. Exposure to RA anteriorized Hoxd4 expression in the hindbrain of wild type (Fig. 4B) , heterozygous (data not shown) and Rarg null animals (Fig. 4C) to the same degree. The overall level of expression in the CNS also appeared to be elevated in RA-treated specimens, although this may be due to increased access by the probe and better visibility of CNS tissue as a result of an open neural tube.
RA treatment did not alter the anterior border or expression level of Hoxd4 in the somitic column of wild type (Fig.  4B ), heterozygous (data not shown) or Rarg null animals (Fig. 4C) . Marginally reduced expression in the untreated wild type embryo (Fig. 4B) is explained by its smaller size. Thus, the loss of Rarg does not affect direct or indirect responses of Hoxd4 to RA, and Hoxd4 is not a target of RA in the rescue of the C2 phenotype.
Discussion
The data presented in this study demonstrate that Hoxd4 and Rarg interact synergistically in the speci®cation of the cervical vertebrae. Hoxd4;Rarg mice presented a morethan-additive increase in penetrance of the overlapping phenotypes observed for each single null mutant. From a morphogenetic standpoint, we favour the model whereby the fusion of the basioccipital bone to the anterior arch of the atlas, and the ectopic anterior arch on C2, are the result of abnormal persistence of the ®rst and third hypochordal (or subnotochordal) bars, as originally proposed by Lohnes et al. (1993) . Hypochordal bars originate from ventral sclerotome and become incorporated into the vertebral body of each vertebra, with the exception of the second hypochordal bar on C1, where it persists and forms the anterior arch of the atlas (Hamilton, 1952) .
The process of chondri®cation only occurs when a mesenchymal condensation reaches a critical mass (Gru Ène- (B) Hoxd4 expression in a wild type embryo 24 h after RA-treatment on day 10.5 (right) is compared to an untreated control. Expression in the hindbrain is anteriorized and appears more intense in the RA-treated embryo, while the somitic expression pattern is highly similar to the control (same embryo as in (A)). (C) Hoxd4 expression in a Rarg null embryo 24 h after RAtreatment on day 10.5 (right) compared to an untreated control. RA induces alterations in the Hoxd4 CNS expression pattern highly similar to those included in wild type embryos, while the somitic expression pattern is unchanged relative to the control (same embryo as in (A)). Note the open neural tube of RA-treated specimens.``Rarg'' denotes Rarg null mutants. berg, 1963; Hall and Miyake, 1992) . The size of the condensation is a function of ®ve cellular parameters: (1) the number of stem cells; (2) the time of condensation initiation; (3) the mitotically active fraction; (4) the rate of cell division; and (5) the rate of cell death (Hall and Miyake, 1992) . Epithelial-mesenchymal interactions are established in the condensation, leading to differentiation of mesenchymal cells and production of extracellular matrix, which trigger chondri®cation (Hall and Miyake, 1992) . Accordingly, the ®rst and third hypochordal bar condensations likely do not normally attain critical mass, and become incorporated into the basioccipital bone and C2, respectively (Hamilton, 1952) . However, in single Hoxd4 or Rarg mutants, and in compound Hoxd4;Rarg mutants at a higher frequency, the hypochordal bars may form larger condensations, attaining critical mass and subsequently chondrifying. The ®rst hypochordal bar would then contribute extra bone between the basioccipital and C1, while the third would develop as an ectopic anterior arch on C2. In support of such a mechanism, misexpression of Hoxd11 in the chick limb bud results in an abnormally large digit I condensation leading to extra skeletal elements (Goff and Tabin, 1997) .
A role for HOX proteins in the regulation of cellular proliferation or cell recruitment for prechondrogenic condensations has been suggested previously (Duboule, 1995) . Overexpression of Hoxd13 in the chick limb causes a decrease in cell proliferation in the proliferative zone of long bone elements (Goff and Tabin, 1997) , supporting a role for Hox genes in the control of cell growth. A number of different direct or indirect downstream targets could be affected in single and compound mutants, which would be the ultimate determinants of cellular proliferation, apoptosis or cell-cell interactions. However, at least in 12.5 and 13.5 day-old embryos, the frequency of proliferative cells in the area of the basioccipital, prevertebra 1 and prevertebra 2 condensations is comparable between compound mutants and wildtype embryos (A.F., H.H. and M.S.F. unpublished observations).
The results reported here reinforce a role for Hoxd4 and Rarg in the negative regulation of chondrogenesis in the ®rst and third hypochordal bars. Both Hox and Rar genes have been previously implicated in the negative regulation of the chondrogenic pathway. The analysis of Hoxa2 null mutants suggests that this gene acts at early stages of the chondrogenic pathway, preventing the induction of Sox9, an early player in cartilage development (Kanzler et al., 1998) . Additionally, there are reports that vitamin A inhibits the expression of the cartilage phenotype by cultured chondrocytes (Zanetti and Solursh, 1989) .
While a distinctly negative role in chondrogenesis is a possibility for Hox genes of the fourth paralogous group, an alternative is that these genes are simply less effective at growth promotion than other Hox family members. According to the model of Goff and Tabin (Goff and Tabin, 1997) , all Hox genes promote growth, but with differing ef®cien-cies. In this scenario, mutation of fourth group paralogs would allow the products of other Hox genes with greater mitogenic potential to occupy target gene regulatory sites and thus direct increased proliferation. We suggest that these stronger mitogens are the products of the third paralogous group for the following reasons. First, the third group genes are also expressed in the cervical prevertebrae. Second, Hoxd3/Hoxb3 double mutants present deletions of C1 (Condie and Capecchi, 1994) . Thus, the tendency for 3rd group compound mutants to lose skeletal elements, while 4th group compound mutants display extra elements with high penetrance, could be explained by a different potential to promote growth of mesenchymal condensations.
Hoxd4 and Rarg could act at different times during the process of hypochordal bar speci®cation and chondri®ca-tion. Hoxd4 is expressed in somitic mesoderm on day 8.5 and persists beyond day 12.5 in prevertebral condensations (Gaunt et al., 1989; Folberg et al., 1997) . Rarg is expressed on day 10.5 in sclerotome, and in prechondrogenic condensations on day 12.5 (Ruberte et al., 1990) . Therefore, Hoxd4 could de®ne the sclerotomal compartment, while both Hoxd4 and Rarg would be active later during migration, proliferation and cell recruitment to the condensation.
Two non-exclusive models could explain the synergistic interactions between Hoxd4 and Rarg. In the ®rst model, Rarg is upstream of Hoxd4 and Hoxb4. Hoxd4 and Hoxb4 cross-regulate each other, and subsequently control downstream targets involved in the chondri®cation of the ®rst and third hypochordal bars. Mutation of Rarg and Hoxd4 would remove two positive regulatory inputs to Hoxb4, reducing its expression. According to this model, Hoxd4;Rarg mutants should phenocopy Hoxd4;Hoxb4 mutants. In support of this, while 20% of Hoxb4 single mutants present an ectopic anterior arch on C2 (Ramõ Ârez-Solis et al., 1993) , the phenotype is fully penetrant in Hoxd4;Hoxb4 double mutants (Horan et al., 1995b) , thus presenting a phenocopy of Hoxd4;Rarg. There is ample precedent for regulation of Hoxb4 by both HOXD4 and RA within neuroectoderm (Gould et al., 1997 (Gould et al., , 1998 . The same may therefore hold true for mesodermal expression. Arguing against Hoxb4 as a primary player in the elaboration of the Hoxd4;Rarg phenotype, is the ®nding that Hoxb4 expression is unaffected in Hoxd4;Rarg compound mutants (Fig. 3) . However, this could be explained by the non-quantitative nature of in situ hybridization, or if the effect on Hoxb4 takes place at a developmental stage other than the one examined.
In the second model, HOXD4 and RARg would act in parallel, regulating common downstream targets in a synergistic fashion. As proposed by Carey (1998) , small combinations of ubiquitous, signal-and tissue-speci®c activators can be used in the cell to execute an exponentially larger number of regulatory decisions, which will ultimately result in speci®city. An enhancer responds to signals by organizing unique combinations of activators in a tightly clustered pattern that promotes their interaction and cooperative binding to DNA (Carey, 1998) . It has been suggested that the binding of factors to a speci®c enhancer site and subsequent gene activation depends on the probability that transactivators will prevail over nucleosomes on those sites (Boyes and Felsenfeld, 1996) . Therefore the number of functional alleles present in Hoxd4;Rarg mutants will determine the amount of functional HOXD4 and RARg available, and will increase (or decrease) the probability that their common downstream targets are activated. In support of this model, our results show a clear allele dosage effect in the penetrance and expressivity of the phenotypes.
BMPs are involved in the speci®cation of dorsomedial sclerotome derivatives, which give rise to the neural aches (Monsoro-Burq et al., 1996) . In contrast, SONIC HEDGE-HOG (SHH), a notochord-¯oor plate signal (Pourquie Â et al., 1993) , induces the ventrolateral sclerotome (Fan and Tessier-Lavigne, 1994) , from which the vertebral body and hypochordal bars originate. Ectopic BMP4 antagonizes the action of SHH on the ventrolateral part of the vertebrae (Monsoro-Burq et al., 1996) . Therefore, it seems unlikely that BMPs would be implicated in the early speci®cation of hypochordal bars. Later in development, BMPR-IB is expressed in vertebral cartilaginous condensations (Zou et al., 1997) , supporting a direct role for BMPs in chondri®ca-tion, and suggesting they may be downstream targets of both Hoxd4 and Rarg at this time.
We found that RA is not able to prevent ectopic anterior arch formation on C2 in Hoxd4 single and Hoxd4;Rarg double mutants, though it does so in single Rarg mutants. Thus, RA-mediated rescue of C2 development requires Hoxd4. However, Hoxd4 expression in somites was unaltered by a 24 h RA treatment beginning on day 10.5 in wildtype and Rarg mutants, suggesting that Hoxd4 and RA provide parallel inputs to the regulation of relevant downstream targets in sclerotomal derivatives. This is in contrast to the action of RARb in the hindbrain which acts upstream of Hoxd4 to anteriorize its expression in response to exogenous RA (Folberg et al., 1999) .
These results suggest a requirement for Hoxd4 function at day 10.5, the time of RA treatment. Interestingly, this is a full two days following the activation of Hoxd4 expression in the somites, suggesting a relatively late or ongoing requirement in axial patterning. This would be consistent with the results of other studies showing that a given Hox gene can have both early and late functions (Castelli-Gair and Akam, 1995; Salser and Kenyon, 1996) . Alternatively, Hoxd4 may be required earlier than day 10.5 to prepare a gene for regulation by RARg later on, for example, through chromatin remodeling.
RA treatment may compensate for the lack of Rarg by activating Rarb or by acting through RARb which is already expressed in sclerotome and prevertebrae. In support of the latter, rescue by RA is ablated in Rara1;Rarg double mutants (A. Iulianella and D.L., unpublished observations). While RARb1 may simply replace RARg to reestablish normal target gene regulation, rescue of the phenotype could be through RA-induced apoptosis of the condensation arising from the third hypochordal bar. This could be comparable to the effect observed in Hammertoe (Hm) mutant mice, where diminished cell death leads to webbing of the foot, and RA-induced apoptosis corrects this phenotype (Ahuja et al., 1997) .
In conclusion, our results provide the ®rst account of synergistic interactions between Hox and retinoic acid receptor genes that occurs speci®cally in somitic derivatives. They support the idea that Hoxd4 and Rarg converge on common genetic pathways, and encourage the search for shared downstream targets involved in this process.
Experimental procedures
Mice
Single Hoxd4 null and Rarg null mice have been previously reported (Lohnes et al., 1993; Horan et al., 1995a) . In our colony, both mutant lines were outbred to CD1 mice. We mated Hoxd42/2 with Rarg1/2 mice to obtain Hoxd4;Rarg double heterozygotes. Brother-sister matings then generated the full set of compound genotypes, from wild-type to double null, which were collected as newborns and prepared for skeleton analysis. Some Hoxd42/2;Rarg1/2 progeny obtained from double heterozygote intercrosses were maintained to generate additional compound mutant specimens for skeletal analysis. In parallel, some Rarg single mutants were derived by Rarg1/ 2 intercrosses. All specimens were genotyped by Southern blot, as described by Lohnes et al. (1993 ) andHoran et al. (1995a . Whole-mount in situ hybridization was performed as previously described (Folberg et al., 1997) .
RA treatment
Pregnant females of Hoxd42/2;Rarg1/2 or Hoxd42/2 genotypes were RA-treated at noon of day 10 of pregnancy. A stock solution of 100 mg/ml all-trans-retinoic acid (Sigma) in DMSO was diluted 10 times in corn oil just before use and delivered to females by oral gavage to a ®nal dose of 100 mg/kg of maternal body weight. Newborns were sacri®ced and prepared for skeleton analysis.
Staining of skeletons
For whole-mount analysis of skeletons, newborn pups were dissected and ®xed for at least 24 h in 95% ethanol. For staining, specimens were treated with 20% acetic acid in ethanol containing 0.15% alcian blue 8GX for 48 h, dehydrated in 95% ethanol for 1 day, followed by 2% potassium hydroxide overnight, and stained in 0.1% aqueous alizarin red with 0.1% potassium hydroxide for 3±5 h. Embryos were cleared in 20% glycerol/1% potassium hydroxide for 1 week and then stored in 50% ethanol/50% glycerol.
